Countries & territories / Mainland
Six distinct ancestral populations, and a working national cohort to prove it.
Population 634,431 (2024) · Part of the PCRA Group's UK, US and Caribbean network.
- Capital
- Paramaribo
- Main languages
- Dutch; Sranan Tongo widely spoken
- Currency
- Surinamese dollar (SRD)
- Population
- 634,431 (2024)
- 27.4%
- Hindustani (East Indian) share of the population; Maroon 21.7%, Creole 15.7%, Javanese 13.7%
- 78.6%
- Of all deaths are from non-communicable disease
- HELISUR
- A published population-based cardiovascular and renal cohort, ethics ref VG021-2012
Why Suriname
Suriname has the most ethnically stratified population in the Americas — Hindustani, Maroon, Creole, Javanese, mixed and Indigenous communities each above 3% of the population — and, unusually for a country of 634,000, it has already run a population-based cardiovascular and renal cohort to prove that multi-ethnic research works there. HELISUR is the evidence that this is not theoretical.
The disease burden
NCDs account for 78.6% of all deaths. Adult obesity is 29.3% overall but 39.2% among women against 19.3% among men. Diabetes prevalence is 20.6% crude. The ancestry stratification means these national figures conceal substantial between-group variation — which for a research sponsor is the opportunity rather than the problem.
Sites and infrastructure
- Academisch Ziekenhuis Paramaribo (Academic Hospital Paramaribo) — 465 beds, the largest hospital in Suriname, an academic hospital since 1969
- Faculty of Medical Sciences, Anton de Kom University of Suriname — a national university medical school
- Established working relationships with Dutch academic centres, including Amsterdam
Research heritage
The HELISUR (Healthy Life in Suriname) study — a population-based cardiovascular and renal cohort run by AZP and Anton de Kom University with Amsterdam academic partners, ethics reference VG021-2012, published in the American Journal of Hypertension and BMC journals. It demonstrates genuine, ethics-approved, multi-ethnic population research capability delivered in-country.
Regulatory & ethics
- Ethics Committee of the Ministry of Health — named explicitly in peer-reviewed ethics statements and demonstrably functioning (HELISUR, ref VG021-2012)
- Clinical trial authorisation body: not separately identifiable; the Ministry of Health route applies
The honest position: No separate national medicines regulatory authority for trial authorisation could be identified, so regulatory timelines are less predictable than in Jamaica or Saint Lucia. Against that, the Ministry of Health Ethics Committee has a documented track record of approving and overseeing a real population cohort — which is more than can be said for several better-resourced territories. Note also that documentation is in Dutch, which adds a translation layer we handle in-house.
Data quality: Moderate to good — Suriname has a real population cohort providing measured local data, though WHO risk-factor estimates still carry wide intervals.
How this site fits the network
Core network site — strong population proposition with a functioning ethics route; research infrastructure developing.
Our Suriname operation is contracted, trained and monitored under the same quality system as our UK and US sites. One master service agreement covers all three regions, one budget negotiation, one set of payment terms. Sites in this network can absorb enrolment from under-recruiting UK or US centres without a new vendor qualification cycle.
Key indicators
| Indicator | Value | Basis |
|---|---|---|
| Adult obesity (BMI ≥30) | 29.3% | Crude, adults 18+, 2022 |
| — women / men | 39.2% / 19.3% | Crude, adults 18+, 2022 |
| Adults overweight or obese | 58.5% | Crude, adults 18+, 2022 |
| Adult diabetes | 20.6% | Crude, adults 18+, 2022 |
| Hypertension | 42.9% | Age-standardised, 30–79, 2019 |
| — of whom controlled | 21.1% | Age-standardised, 2019 |
| NCDs as share of all deaths | 78.6% | 2019 |
| Premature NCD mortality (30–70) | 18.7% | Probability of death, 2021 |
All figures are WHO Global Health Observatory modelled estimates on one consistent basis: obesity, overweight and diabetes are crude prevalence, adults 18+, 2022; hypertension and control are age-standardised, adults 30–79, 2019; NCD share of deaths is 2019; premature NCD mortality is the probability of dying between 30 and 70 from a major NCD, 2021. Estimates carry confidence intervals — we quote intervals on request and always where they are wide.
Member sites in Suriname
Our anonymised directory shows the network's research-ready sites — sponsors can register for full site details, including which countries and territories each site serves.
Browse member sitesPlanning a study in Suriname?
Tell us what your protocol needs and we'll give you an honest feasibility read — and if you run a hospital, clinic, pharmacy, lab or research unit in Suriname, we'd love to hear from you too.